United States (US) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The US pharmaceuticals market had total revenues of $408.0 billion in 2022, representing a compound annual growth rate (CAGR) of 4.1% between 2017 and 2022.
0
According to in-house research, in 2022, the US accounted for 31.4% of the global pharmaceuticals market. The FDA regulates the pharmaceutical industry in the US, approving 12% of drugs submitted for clinical testing annually. The rigorous clinical trial process results in additional spending on research and development.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the United States pharmaceuticals market by value in 2022?
What will be the size of the United States pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the United States pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the United States's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 Company Profiles

8.1. Johnson & Johnson
8.2. Merck & Co., Inc.
8.3. Pfizer Inc.
8.4. AstraZeneca PLC

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: United States pharmaceuticals market value: $ billion, 2017-22
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: United States pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Johnson & Johnson: key facts
Table 5: Johnson & Johnson: Annual Financial Ratios
Table 6: Johnson & Johnson: Key Employees
Table 7: Johnson & Johnson: Key Employees Continued
Table 8: Merck & Co., Inc.: key facts
Table 9: Merck & Co., Inc.: Annual Financial Ratios
Table 10: Merck & Co., Inc.: Key Employees
Table 11: Merck & Co., Inc.: Key Employees Continued
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: AstraZeneca PLC: Key Employees Continued
Table 20: United States size of population (million), 2018-22
Table 21: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 22: United States gdp (current prices, $ billion), 2018-22
Table 23: United States inflation, 2018-22
Table 24: United States consumer price index (absolute), 2018-22
Table 25: United States exchange rate, 2018-22

List of Figures

Figure 1: United States pharmaceuticals market value: $ billion, 2017-22
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
AstraZeneca PLC

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€348EUR$350USD£289GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€522EUR$525USD£434GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€695EUR$700USD£578GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

Specialty Pharmaceuticals Market 2024-2028

Pharmaceutical Market in Canada 2024-2028

Ethical Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028